Article Text
Statistics from Altmetric.com
- angioplasty
- transluminal
- percutaneous coronary
- coronary artery bypass
- coronary disease
- vascular surgical procedures
Q In patients with stable coronary artery disease (CAD) who are scheduled for elective major vascular surgery, does prophylactic coronary artery revascularisation reduce long term, all cause mortality?
Clinical impact ratings GP/FP/Primary care ★★★★★★☆ IM/Ambulatory care ★★★★★★☆ Internal medicine ★★★★★★☆ Cardiology ★★★★★★☆
METHODS
Design:
randomised controlled trial (RCT) (Coronary Artery Revascularization Prophylaxis [CARP] trial).
Allocation:
{concealed*}†.
Blinding:
blinded ({investigators}† and the endpoints committee that validated all outcomes).*
Follow up period:
median 2.7 years.
Setting:
18 Veterans Affairs medical centres in the US.
Patients:
510 patients (mean age 66 y, 98% men) with stable CAD (⩾70% stenosis in ⩾1 major coronary artery suitable for revascularisation) who were scheduled for elective major vascular operation for an expanding abdominal aortic aneurysm or severe symptoms of …